CCL20 and cystic fibrosis: Based on the here identified chemotactic potential of CCL20 on human ILC2s, we suggest that decreased numbers of CCR6+ ILC2s in the peripheral blood of CF patients reflect the enhanced attraction of these cells to the site of inflammation.